Clinical Trial Update: A Phase I/II Study With BM7PE Immunotoxin in Colorectal Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study update on BM7PE immunotoxin in metastatic colorectal cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• BM7PE immunotoxin

Snippet

Sponsor: Oslo University Hospital | Conditions: Colorectal Cancer Metastatic | Phase 1, Phase 2 | Status: UNKNOWN